Renovaro Biosciences
Quarterly Financials
| Values in thousands | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $181 | $0 |
Gross Profit | -31 | -32 | -32 | -30 |
EBITDA | 409 | -7,121 | -43,929 | -50,880 |
EBIT | 377 | -7,153 | -43,961 | -50,910 |
Net Income | 189 | -7,252 | -44,212 | -17,024 |
Net Change In Cash | 0 | 0 | 181 | 0 |
Free Cash Flow | 11,804,307,399 | -2,559 | -2,016 | -2,639 |
Cash | 923 | 311 | 220 | 312 |
Basic Shares | 163,930 | 161,825 | 156,567 | 107,480 |
Annual Financials
| Values in thousands | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -121 | -113 | -123 |
EBITDA | -79,516 | -19,483 | -22,702 |
EBIT | -79,638 | -19,596 | -22,826 |
Net Income | -80,650 | -39,684 | -113,433 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -11,041 | -11,804 | -15,737 |
Cash | 220 | 1,874 | 9,172 |
Basic Shares | 96,248 | 56,265 | 52,528 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-03-31 | $0.001 |
2024-12-31 | -$0.04 |
2024-09-30 | -$0.28 |
2024-06-30 | -$0.14 |
